Chronic Pain News and Research

RSS

Some Minn. insurers will end certain Medicare plans; Utah issues rule on child-only plans; Fla. law on pain clinics takes effect

Five insurance companies including Minnetonka-based Medica next year will stop providing a particular type of Medicare health plan in much of Minnesota, a state official said Thursday.

4 Oct 2010

NIH funds $1.5M for research into prediction of stroke risk in pediatric patients with sickle cell disease

A researcher from the biomedical engineering department operated by Georgia Tech and Emory University has received a $1.5 million NIH Director's New Innovator Award to support a project aimed at reducing the incidence of stroke in children with sickle cell disease. Manu Platt, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering, will use the National Institutes of Health (NIH) funding to develop models for identifying which children with the disease are at risk for stroke.

1 Oct 2010

New RF detection device may help eliminate retained surgical sponges in patients after surgical procedure

Using the same technology found in clothing tags used in retail store tracking systems, a study from the University of North Carolina at Chapel Hill shows that surgical sponges with implanted radio frequency (RF) tags may be an effective adjunct to manual counting and X-ray detection in preventing sponges from being left behind in patients following a surgical procedure.

1 Oct 2010

St. Jude Medical receives Japanese approval for Eon Mini spinal cord stimulation system

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) of the Eon Mini™ spinal cord stimulation (SCS) system. The world's smallest, longest-lasting rechargeable neurostimulator, the Eon Mini device is the first rechargeable spinal cord stimulator to be approved for use in Japan.

30 Sep 2010

Inefficiencies in treatment of chronic pain increases healthcare costs and prolongs patient suffering

A new report launched today in the European Parliament shows inefficiencies in the treatment of chronic pain result in increasing healthcare costs and prolonged patient suffering.

29 Sep 2010

SCS, PNS prove to be effective tools in treating chronic pain: NANS, ASIPP

Afflicting countless people worldwide, chronic pain is a largely misunderstood and under-treated disease that forever alters the lives of more than 50 million Americans each year.

28 Sep 2010

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic low back pain have been published online by Expert Opinion on Pharmacotherapy. In addition, this study compared oxycodone controlled-release (CR) to placebo as an active control.

28 Sep 2010

Sensitizing effect of anger and sadness not limited to fibromyalgia patients

Researchers from Utrecht University who studied the effect of negative emotions on pain perception in women with and without fibromyalgia found that anger and sadness amplified pain equally in both groups. Full findings are now online and will publish in the October 2010 print issue of Arthritis Care & Research, a journal of the American College of Rheumatology.

24 Sep 2010

FDA grants priority review status for Endo’s oxymorphone oral formulation

Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.

23 Sep 2010

APF launches new educational initiative for people with pain, health care professionals

The American Pain Foundation today announced the launch of PainSAFE (Pain Safety & Access For Everyone), a new educational initiative designed for people with pain and health care professionals. The mission of PainSAFE is to provide education surrounding the appropriate and safe use of pain management therapies for people affected by pain and health care professionals, thereby, helping to reduce risk and improve access to quality pain care.

22 Sep 2010

Communication breakdown exists between people with chronic pain, health care providers: Survey

Conversations with health care providers can be challenging at times for all patients, but a new survey commissioned by HealthyWomen and conducted by Synovate Healthcare in July of 2010 reveals a concerning communications breakdown between people with chronic pain and their health care providers. More than one-third of chronic pain sufferers (36%) have simply learned to live with their often debilitating pain and may be reluctant to speak with a health care provider about their condition, according to a survey of women and men with chronic pain released today.

22 Sep 2010

Researchers discover new drug to control acute and chronic pain

American and Italian researchers have found that a novel drug allows anandamide a marijuana like chemical in the body to effectively control pain at the site of an injury.

21 Sep 2010

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Athena™ programmer, a deep brain stimulation (DBS) therapy management system. This next-generation platform offers clinicians a powerful yet easy-to-use interface that enables them to set or adjust therapeutic parameters to optimize patient results.

20 Sep 2010

$ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study$

ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study

Medtronic, Inc. announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise for occipital nerve stimulation for treating medically refractory chronic migraines and support the need for further controlled study of the treatment. The study, called Occipital Nerve Stimulation for the Treatment of Intractable Migraine, included severely debilitated patients who had regularly experienced 15 or more headache days per month that were not responsive to currently available medical therapies.

18 Sep 2010

ACTION Ontario applauds Narcotics Safety and Awareness bill

ACTION Ontario, a non-profit group advocating on behalf of chronic pain sufferers, applauds the provincial government's Narcotics Safety and Awareness bill and encourages the government to take the next step and also address the underlying issue of pain with a comprehensive strategy.

17 Sep 2010

Spike mat reduces muscle tension pain: Study

Spike mats do not alleviate chronic pain. Nor do they lead to a better night's sleep. But pain sufferers who have tested a spike mat did experience a measurable reduction in the worst peaks of pain. This is shown in a research study performed at Karlstad University in Sweden.

17 Sep 2010

FDA-cleared LaserTouchOne device for chronic and acute pain treatment available without prescription

The American Pain Foundation reports that despite the fact that the majority of the U.S. population looks healthy, statistics tell a different story: Approximately 1 in 3 Americans suffer from chronic pain. This chronic pain could be related to an illness like cancer or rheumatoid arthritis, or a condition such as arthritis, migraine headaches, fibromyalgia or back pain from a car accident.

15 Sep 2010

FDA grants Arcion's ARC-4558 Fast Track designation for pain involved in Painful Diabetic Neuropathy

Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ARC-4558 for the treatment of pain associated with Painful Diabetic Neuropathy (PDN).

15 Sep 2010

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.

14 Sep 2010

RS Medical receives Federal Supply Schedule contract

International Rehabilitative Sciences, Inc. d/b/a RS Medical, announced today its first award of a Federal Supply Schedule contract. The contract is in effect through June 14, 2015.

14 Sep 2010

Chronic Pain News and Research

Some Minn. insurers will end certain Medicare plans; Utah issues rule on child-only plans; Fla. law on pain clinics takes effect

NIH funds $1.5M for research into prediction of stroke risk in pediatric patients with sickle cell disease

New RF detection device may help eliminate retained surgical sponges in patients after surgical procedure

St. Jude Medical receives Japanese approval for Eon Mini spinal cord stimulation system

Inefficiencies in treatment of chronic pain increases healthcare costs and prolongs patient suffering

SCS, PNS prove to be effective tools in treating chronic pain: NANS, ASIPP

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

Sensitizing effect of anger and sadness not limited to fibromyalgia patients

FDA grants priority review status for Endo’s oxymorphone oral formulation

APF launches new educational initiative for people with pain, health care professionals

Communication breakdown exists between people with chronic pain, health care providers: Survey

Researchers discover new drug to control acute and chronic pain

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study

ACTION Ontario applauds Narcotics Safety and Awareness bill

Spike mat reduces muscle tension pain: Study

FDA-cleared LaserTouchOne device for chronic and acute pain treatment available without prescription

FDA grants Arcion's ARC-4558 Fast Track designation for pain involved in Painful Diabetic Neuropathy

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

RS Medical receives Federal Supply Schedule contract

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News